595 related articles for article (PubMed ID: 25708195)
21. Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47.
Soto-Pantoja DR; Stein EV; Rogers NM; Sharifi-Sanjani M; Isenberg JS; Roberts DD
Expert Opin Ther Targets; 2013 Jan; 17(1):89-103. PubMed ID: 23101472
[TBL] [Abstract][Full Text] [Related]
22. Thrombospondin-1/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells.
Bissinger R; Petkova-Kirova P; Mykhailova O; Oldenborg PA; Novikova E; Donkor DA; Dietz T; Bhuyan AAM; Sheffield WP; Grau M; Artunc F; Kaestner L; Acker JP; Qadri SM
Cell Commun Signal; 2020 Sep; 18(1):155. PubMed ID: 32948210
[TBL] [Abstract][Full Text] [Related]
23. Is CD47 a potentially promising therapeutic target in cardiovascular diseases? - Role of CD47 in cardiovascular diseases.
Cheng Q; Gu J; Adhikari BK; Sun L; Sun J
Life Sci; 2020 Apr; 247():117426. PubMed ID: 32061866
[TBL] [Abstract][Full Text] [Related]
24. The use of CD47-modified biomaterials to mitigate the immune response.
Tengood JE; Levy RJ; Stachelek SJ
Exp Biol Med (Maywood); 2016 May; 241(10):1033-41. PubMed ID: 27190273
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer.
Roberts DD; Kaur S; Soto-Pantoja DR
J Cell Commun Signal; 2015 Mar; 9(1):101-2. PubMed ID: 25779848
[TBL] [Abstract][Full Text] [Related]
26. Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma.
Zhang X; Chen W; Fan J; Wang S; Xian Z; Luan J; Li Y; Wang Y; Nan Y; Luo M; Li S; Tian W; Ju D
Carcinogenesis; 2018 May; 39(5):689-699. PubMed ID: 29538621
[TBL] [Abstract][Full Text] [Related]
27. A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer.
Kaur S; Elkahloun AG; Singh SP; Chen QR; Meerzaman DM; Song T; Manu N; Wu W; Mannan P; Garfield SH; Roberts DD
Oncotarget; 2016 Mar; 7(9):10133-52. PubMed ID: 26840086
[TBL] [Abstract][Full Text] [Related]
28. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.
Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS
Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180
[TBL] [Abstract][Full Text] [Related]
29. Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.
Isenberg JS; Maxhimer JB; Hyodo F; Pendrak ML; Ridnour LA; DeGraff WG; Tsokos M; Wink DA; Roberts DD
Am J Pathol; 2008 Oct; 173(4):1100-12. PubMed ID: 18787106
[TBL] [Abstract][Full Text] [Related]
30. Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.
Rogers NM; Sharifi-Sanjani M; Csányi G; Pagano PJ; Isenberg JS
Matrix Biol; 2014 Jul; 37():92-101. PubMed ID: 24418252
[TBL] [Abstract][Full Text] [Related]
31. CD47 in the immune response: role of thrombospondin and SIRP-alpha reverse signaling.
Sarfati M; Fortin G; Raymond M; Susin S
Curr Drug Targets; 2008 Oct; 9(10):842-50. PubMed ID: 18855618
[TBL] [Abstract][Full Text] [Related]
32. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages.
Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y
J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683
[TBL] [Abstract][Full Text] [Related]
33. Emerging functions of thrombospondin-1 in immunity.
Kaur S; Roberts DD
Semin Cell Dev Biol; 2024 Mar; 155(Pt B):22-31. PubMed ID: 37258315
[TBL] [Abstract][Full Text] [Related]
34. Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1.
Kaur S; Kuznetsova SA; Pendrak ML; Sipes JM; Romeo MJ; Li Z; Zhang L; Roberts DD
J Biol Chem; 2011 Apr; 286(17):14991-5002. PubMed ID: 21343308
[TBL] [Abstract][Full Text] [Related]
35. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.
Hatherley D; Graham SC; Turner J; Harlos K; Stuart DI; Barclay AN
Mol Cell; 2008 Jul; 31(2):266-77. PubMed ID: 18657508
[TBL] [Abstract][Full Text] [Related]
36. Roles of TSP1-CD47 signaling pathway in senescence of endothelial cells: cell cycle, inflammation and metabolism.
Zhao W; Shen B; Cheng Q; Zhou Y; Chen K
Mol Biol Rep; 2023 May; 50(5):4579-4585. PubMed ID: 36897523
[TBL] [Abstract][Full Text] [Related]
37. Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling.
Maxhimer JB; Soto-Pantoja DR; Ridnour LA; Shih HB; Degraff WG; Tsokos M; Wink DA; Isenberg JS; Roberts DD
Sci Transl Med; 2009 Oct; 1(3):3ra7. PubMed ID: 20161613
[TBL] [Abstract][Full Text] [Related]
38. CD47 and Nox1 Mediate Dynamic Fluid-Phase Macropinocytosis of Native LDL.
Csányi G; Feck DM; Ghoshal P; Singla B; Lin H; Nagarajan S; Meijles DN; Al Ghouleh I; Cantu-Medellin N; Kelley EE; Mateuszuk L; Isenberg JS; Watkins S; Pagano PJ
Antioxid Redox Signal; 2017 Jun; 26(16):886-901. PubMed ID: 27958762
[TBL] [Abstract][Full Text] [Related]
39. Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro.
Stefanidakis M; Newton G; Lee WY; Parkos CA; Luscinskas FW
Blood; 2008 Aug; 112(4):1280-9. PubMed ID: 18524990
[TBL] [Abstract][Full Text] [Related]
40. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha.
Liu Y; O'Connor MB; Mandell KJ; Zen K; Ullrich A; Bühring HJ; Parkos CA
J Immunol; 2004 Feb; 172(4):2578-85. PubMed ID: 14764731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
